Table 1.
Authors (Year) | Year(s) of Data Collection | Country | Study Site | Study Design | Sampling Method | Population | HSV-1 Serological Assay | Sample Size, No. | HSV-1 Seroprevalence, % |
---|---|---|---|---|---|---|---|---|---|
Healthy Children Populations (n = 19) | |||||||||
Bogaerts et al (2001) [49] | 1996–1998 | Bangladesh | Outpatient clinic | CS | Conv | 1–12-y-old children | WB | 79 | 46.0 |
Chang (1986) [50] | 1984–1986 | China | Hospital | CS | Conv | 7–12-mo-old infants | CFT | 31 | 41.9 |
Chang (1986) [50] | 1984–1987 | China | Hospital | CS | Conv | 13–24-mo-old children | CFT | 31 | 51.6 |
Chang (1986) [50] | 1984–1988 | China | Hospital | CS | Conv | 24–35-mo-old children | CFT | 30 | 43.3 |
Chang (1986) [50] | 1984–1989 | China | Hospital | CS | Conv | 3–4-y-old children | CFT | 31 | 67.7 |
Chang (1986) [50] | 1984–1990 | China | Hospital | CS | Conv | 5–6-y-old children | CFT | 31 | 48.4 |
Chang (1986) [50] | 1984–1991 | China | Hospital | CS | Conv | 7–8-y-old children | CFT | 31 | 71.0 |
Chang (1986) [50] | 1984–1992 | China | Hospital | CS | Conv | 9–14-y-old children | CFT | 31 | 74.2 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 1-y-old children | ELISA | 90 | 11.1 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 2-y-old children | ELISA | 127 | 14.2 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 3-y-old children | ELISA | 92 | 31.5 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 4-y-old children | ELISA | 84 | 23.8 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 5–9-y-old children | ELISA | 111 | 46.8 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 10–14-y-old children | ELISA | 92 | 46.7 |
Li et al (1990) [52] | 1988–1989 | China | Community | CS | Conv | 1–10-y-old Koreans | PHA | 16 | 38.0 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 5–9-y-old girls | ELISA | 40 | 64.9 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 10–14-y-old girls | ELISA | 45 | 78.3 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 5–9-y-old boys | ELISA | 75 | 59.8 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 10–14-y-old boys | ELISA | 64 | 78.0 |
Healthy Adult Populations (n = 103) | |||||||||
Armelia et al (2012) [54] | 2010–2011 | Indonesia | Hospital | CSa | Conv | Kidney donors | Anti-HSV-1 IgG | 23 | 72.7 |
Ashley et al (2004) [55] | 2000–2001 | Thailand | Community | CS | Conv | ≥15-y-old women in Lampang | WB | 98 | 92.9 |
Ashley et al (2004) [55] | 2000–2001 | Thailand | Community | CS | Conv | ≥15-y-old women in Songkla | WB | 90 | 61.1 |
Ashley et al (2004) [55] | 2000–2001 | Vietnam | Community | CS | Conv | ≥15-y-old women in Hanoi | WB | 99 | 100.0 |
Ashley et al (2004) [55] | 2000–2001 | Vietnam | Community | CS | Conv | ≥15-y-old women in Ho Chi Minh | WB | 100 | 98.0 |
Bogaerts et al (2001) [49] | 1996–1998 | Bangladesh | Outpatient clinic | CS | Conv | Healthy women | ELISA | 183 | 97.0 |
Bu et al (2015) [45] | 2012–2013 | China | Hospital | CC | Conv | Healthy individuals | ELISA | 135 | 78.5 |
Chang (1986) [50] | 1984–1986 | China | Hospital | CS | Conv | >14-y-old adults | CFT | 30 | 93.3 |
Cowan et al (2003) [56] | 1998–2000 | India | Community | CS | Conv | 15–20-y-old adults | ELISA | 239b | 85.7 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 15–19-y-old adults | ELISA | 115 | 53.0 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 20–29-y-old adults | ELISA | 123 | 69.9 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 30–39-y-old adults | ELISA | 129 | 84.5 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 40–49-y-old adults | ELISA | 100 | 94.0 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 50–59-y-old adults | ELISA | 91 | 98.9 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | 60–69-y-old adult | ELISA | 122 | 100 |
Chen et al (2013) [51] | 2007 | Taiwan | Community | CS | Conv | >70-y-old adults | ELISA | 96 | 100 |
Cowan et al (2003) [56] | 1998–2000 | India | Community | CS | Conv | 20–30-y-old adults | ELISA | 239b | 79.9 |
Cowan et al (2003) [56] | 1998–2000 | India | Community | CS | Conv | 30–35-y-old adults | ELISA | 239b | 80.0 |
Cowan et al (2003) [56] | 1998–2000 | India | Community | CS | Conv | 25–40-y-old adults | ELISA | 239b | 84.8 |
Cowan et al (2003) [56] | 1998–2000 | India | Community | CS | Conv | 40–45-y-old adults | ELISA | 239b | 86.2 |
Cowan et al (2003) [56] | 1998–2000 | India | Community | CS | Conv | >45-y-old adults | ELISA | 239b | 92.5 |
Doi et al (2009) [57] | 2002 | Japan | Community | CSa | RS | 18–29-y-old women | ELISA | 83 | 45.8 |
Doi et al (2009) [57] | 2002 | Japan | Community | CSa | RS | 30–39-y-old women | ELISA | 184 | 50.5 |
Doi et al (2009) [57] | 2002 | Japan | Community | CSa | RS | 40–49-y-old women | ELISA | 198 | 66.7 |
Doi et al (2009) [57] | 2002 | Japan | Community | CSa | RS | 50–59-y-old women | ELISA | 200 | 79.0 |
Doi et al (2009) [57] | 2002 | Japan | Community | CSa | RS | 18–29-y-old men | ELISA | 45 | 44.4 |
Doi et al (2009) [57] | 2002 | Japan | Community | CSa | RS | 30–39-y-old men | ELISA | 129 | 44.2 |
Doi et al (2009) [57] | 2002 | Japan | Community | CSa | RS | 40–49-y-old men | ELISA | 198 | 49.0 |
Doi et al (2009) [57] | 2002 | Japan | Community | CSa | RS | 50–59-y-old men | ELISA | 198 | 71.7 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | <30-y-old men blood donors | EIA | 12 | 33.0 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | 30–50-y-old men blood donors | EIA | 17 | 70.0 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | >50-y-old men blood donors | EIA | 12 | 92.0 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | 20–39-y-old healthy women | EIA | 20 | 65.0 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | 40–99-y-old healthy women | EIA | 28 | 89.0 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | >50-y-old healthy women | EIA | 27 | 92.5 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | Pregnant women from Tokyo | EIA | 58 | 47.0 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | Pregnant women from Kagoshima | EIA | 100 | 61.0 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 20–29-y-old men in 1973 | ELISA | 31 | 64.5 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 30–39-y-old men in 1973 | ELISA | 25 | 76.0 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 40–49-y-old men in 1973 | ELISA | 15 | 86.7 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 20–29-y-old men in 1983 | ELISA | 24 | 37.5 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 30–39-y-old men in 1983 | ELISA | 30 | 76.7 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 40–49-y-old men in 1983 | ELISA | 33 | 90.9 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 20–29-y-old men in 1993 | ELISA | 30 | 33.3 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 30–39-y-old men in 1993 | ELISA | 30 | 56.7 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 40–49-y-old men in 1993 | ELISA | 45 | 75.6 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 20–29-y-old women in 1973 | ELISA | 32 | 59.4 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 30–39-y-old women in 1973 | ELISA | 33 | 84.8 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 40–49-y-old women in 1973 | ELISA | 23 | 100.0 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 20–29-y-old women in 1983 | ELISA | 35 | 51.4 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 30–39-y-old women in 1983 | ELISA | 36 | 77.8 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 40–49-y-old women in 1983 | ELISA | 34 | 97.1 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 20–29-y-old women in 1993 | ELISA | 63 | 31.7 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 30–39-y-old women in 1993 | ELISA | 54 | 69.1 |
Hashido et al (1999) [59] | 1973–1993 | Japan | Community | CS | Conv | 40–49-y-old women in 1993 | ELISA | 41 | 80.5 |
Kaur et al (1999) [60] | NA | India | Outpatient clinic | CS | Conv | 16–20-y-old pregnant women | EIA | 24 | 50.0 |
Kaur et al (1999) [60] | NA | India | Outpatient clinic | CS | Conv | 21–25-y-old pregnant women | EIA | 36 | 44.4 |
Kaur et al (1999) [60] | NA | India | Outpatient clinic | CS | Conv | 26–30-y-old pregnant women | EIA | 34 | 55.8 |
Kaur et al (1999) [60] | NA | India | Outpatient clinic | CS | Conv | 31–35-y-old pregnant women | EIA | 14 | 14.1 |
Kaur et al (1999) [60] | NA | India | Outpatient clinic | CS | Conv | >36-y-old pregnant women | EIA | 12 | 83.3 |
Kaur et al (2005) [61] | NA | India | Outpatient clinic | CS | Conv | 16–20-y-old women | ELISA | 12 | 50.0 |
Kaur et al (2005) [61] | NA | India | Outpatient clinic | CS | Conv | 21–25-y-old women | ELISA | 17 | 47.1 |
Kaur et al (2005) [61] | NA | India | Outpatient clinic | CS | Conv | 26–30-y-old women | ELISA | 18 | 50.0 |
Kaur et al (2005) [61] | NA | India | Outpatient clinic | CS | Conv | 31–40-y-old women | ELISA | 13 | 46.1 |
Kaur et al (2005) [61] | NA | India | Outpatient clinic | CS | Conv | 16–20-y-old men | ELISA | 13 | 46.1 |
Kaur et al (2005) [61] | NA | India | Outpatient clinic | CS | Conv | 21–25-y-old men | ELISA | 20 | 25.0 |
Kaur et al (2005) [61] | NA | India | Outpatient clinic | CS | Conv | 26–30-y-old men | ELISA | 14 | 71.4 |
Kaur et al (2005) [61] | NA | India | Outpatient clinic | CS | Conv | 31–40-y-old men | ELISA | 13 | 46.1 |
Li et al (1990) [52] | 1988–1989 | China | Community | CS | Conv | >21-y-old Hans Chinese | PHA | 78 | 99.0 |
Li et al (1990) [52] | 1988–1989 | China | Community | CS | Conv | >21-y-old Koreans | PHA | 34 | 97.0 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 15–19-y-old women | ELISA | 78 | 87.5 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 20–24-y-old women | ELISA | 101 | 86.1 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 25–29-y-old women | ELISA | 135 | 93.3 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 30–34-y-old women | ELISA | 152 | 96.7 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 35–39-y-old women | ELISA | 154 | 95.5 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 40–44-y-old women | ELISA | 129 | 98.4 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 45–49-y-old women | ELISA | 97 | 98.0 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 50–54-y-old women | ELISA | 101 | 98.1 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 55–60-y-old women | ELISA | 44 | 97.8 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 15–19-y-old men | ELISA | 89 | 76.5 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 20–24-y-old men | ELISA | 93 | 81.9 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 25–29-y-old men | ELISA | 112 | 86.5 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 30–34-y-old men | ELISA | 137 | 90.4 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 35–39-y-old men | ELISA | 144 | 93.7 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 40–44-y-old men | ELISA | 118 | 97.4 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 45–49-y-old men | ELISA | 89 | 96.7 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 50–54-y-old men | ELISA | 82 | 98.7 |
Lin et al (2011) [53] | 2006 | China | Community | CS | RS | 55–60-y-old men | ELISA | 62 | 98.4 |
Nasrallah GK, Dargham SR, Harfouche M, and Abu-Raddad LJ (2018, unpublished data) | 2013–2016 | India | Community | CS | Conv | <24-y-old Indian men | ELISA | 40 | 40.0 |
Nasrallah GK, Dargham SR, Harfouche M, and Abu-Raddad LJ (2018, unpublished data) | 2013–2016 | India | Community | CS | Conv | 25–29-y-old Indian men | ELISA | 49 | 34.0 |
Nasrallah GK, Dargham SR, Harfouche M, and Abu-Raddad LJ (2018, unpublished data) | 2013–2016 | India | Community | CS | Conv | 30–34-y-old Indian men | ELISA | 50 | 60.0 |
Nasrallah GK, Dargham SR, Harfouche M, and Abu-Raddad LJ (2018, unpublished data) | 2013–2016 | India | Community | CS | Conv | 35–39-y-old Indian men | ELISA | 50 | 36.0 |
Nasrallah GK, Dargham SR, Harfouche M, and Abu-Raddad LJ (2018, unpublished data) | 2013–2016 | India | Community | CS | Conv | 40–44-y-old Indian men | ELISA | 50 | 48.0 |
Nasrallah GK, Dargham SR, Harfouche M, and Abu-Raddad LJ (2018, unpublished data) | 2013–2016 | India | Community | CS | Conv | 45–49-y-old Indian men | ELISA | 50 | 58.0 |
Nasrallah GK, Dargham SR, Harfouche M, and Abu-Raddad LJ (2018, unpublished data) | 2013–2016 | India | Community | CS | Conv | >50-y-old Indian men | ELISA | 35 | 62.0 |
Nasrallah GK, Dargham SR, Harfouche M, and Abu-Raddad LJ (2018, unpublished data) | 2013–2016 | Philippines | Community | CS | Conv | <34-y-old Filipino men | ELISA | 52 | 84.6 |
Nasrallah GK, Dargham SR, Harfouche M, and Abu-Raddad LJ (2018, unpublished data) | 2013–2016 | Philippines | Community | CS | Conv | 35–44-y-old Filipino men | ELISA | 40 | 82.5 |
Nasrallah GK, Dargham SR, Harfouche M, and Abu-Raddad LJ (2018, unpublished data) | 2013–2016 | Philippines | Community | CS | Conv | >45-y-old Filipino men | ELISA | 28 | 85.7 |
Patnaik et al (2007) [62] | 1985–2007 | Thailand | Hospital | CC | Conv | Healthy women | WB | 78 | 51.3 |
Schmid et al (1999) [63] | 1991–1993 | Thailand | Hospital | CS | Conv | >21-y-old army men | WB | 1158 | 77.9 |
Shivaswamy et al (2005) [64] | 2001–2003 | India | Outpatient clinic | CC | Conv | Healthy individuals | ELISA | 135 | 91.8 |
Yue (1990) [65] | 1987–1989 | China | Outpatient clinic | CS | Conv | Pregnant women | ELISA | 295 | 82.0 |
Zegans et al (1999) [66] | 1997 | India | Hospital | CC | Conv | Controls for a study of Mooren ulcer | ELISA | 44 | 64.0 |
Healthy Mixed-Age Populations (n = 4) | |||||||||
Li et al (1990) [52] | 1988–1989 | China | Community | CS | Conv | 11–20-y-old Hans Chinese | PHA | 17 | 94.1 |
Li et al (1990) [52] | 1988–1989 | China | Community | CS | Conv | 11–20-y-old Koreans | PHA | 13 | 85.0 |
Shen et al (2015) [67] | 2007 | Taiwan | Community | CS | RS | Healthy women | ELISA | 830 | 64.5 |
Shen et al (2015) [67] | 2007 | Taiwan | Community | CS | RS | Healthy men | ELISA | 581 | 52.0 |
Clinical Children Populations (n = 7) | |||||||||
Cowan et al (2003) [56] | 1998–2000 | India | Hospital | CS | Conv | 1–5-y-old children | ELISA | 90b | 40.2 |
Cowan et al (2003) [56] | 1998–2000 | India | Hospital | CS | Conv | 5–10-y-old children | ELISA | 90b | 68.4 |
Cowan et al (2003) [56] | 1998–2000 | India | Hospital | CS | Conv | 10–15-y-old children | ELISA | 90b | 75.9 |
Cowan et al (2003) [56] | 1998–2000 | Sri Lanka | Hospital | CS | Conv | 1–5-y-old children | ELISA | 144b | 40.5 |
Cowan et al (2003) [56] | 1998–2000 | Sri Lanka | Hospital | CS | Conv | 5–10-y-old children | ELISA | 144b | 53.1 |
Cowan et al (2003) [56] | 1998–2000 | Sri Lanka | Hospital | CS | Conv | 10–15-y-old children | ELISA | 144b | 74.0 |
Shymala et al (2008) [68] | 2005–2006 | India | Outpatient clinic | CS | Conv | Infants with congenital cataract | ELISA | 18 | 16.7 |
Clinical Adult Populations (n = 23) | |||||||||
Armelia et al (2012) [54] | 2010–2011 | Indonesia | Hospital | CSa | Conv | Pre–kidney transplant patients | Anti-HSV-1 IgG | 23 | 68.2 |
Bu et al (2015) [45] | 2012–2013 | China | Hospital | CC | Conv | Patients with Alzheimer disease | ELISA | 128 | 85.2 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | <39-y-old patients with STD | EIA | 10 | 60.0 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | >40-y-old patients with STD | EIA | 16 | 81.2 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | Pregnant Tokyo women with HTLV-1 | EIA | 32 | 56.0 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | Pregnant Kagoshima women with HTLV-1 | EIA | 100 | 83.0 |
Kaur et al (2006) [69] | NA | India | Outpatient clinic | CS | Conv | Women attending an STD clinic | ELISA | 52 | 82.7 |
Kaur et al (2006) [69] | NA | India | Outpatient clinic | CS | Conv | Women attending an STD clinic | ELISA | 76 | 73.7 |
Patwardhan and Bhalla (2016) [70] | NA | India | Hospital | CS | Conv | Patients with first genital herpes | ELISA | 21 | 42.8 |
Patwardhan and Bhalla (2016) [70] | NA | India | Hospital | CS | Conv | Patients with recurrent genital herpes | ELISA | 23 | 65.2 |
Shivaswamy et al (2005) [64] | 2001–2003 | India | Outpatient clinic | CC | Conv | <40-y-old patients in an STI clinic | ELISA | 111 | 90.1 |
Shivaswamy et al (2005) [64] | 2001–2003 | India | Outpatient clinic | CC | Conv | ≥40-y-old patients in an STI clinic | ELISA | 24 | 95.8 |
Sun et al (2005) [48] | NA | China | Hospital | CS | Conv | Diabetic inpatients | ELISA | 206 | 46.1 |
Sun et al (2005) [48] | NA | China | Hospital | CS | Conv | Nondiabetic inpatients | ELISA | 1360 | 36.3 |
Theng et al (2006) [71] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | <29-y-old men | ELISA | 72 | 47.2 |
Theng et al (2006) [71] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | 30–39-y-old men | ELISA | 50 | 52.0 |
Theng et al (2006) [71] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | 40–49-y-old men | ELISA | 41 | 58.8 |
Theng et al (2006) [71] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | >50-y-old men | ELISA | 37 | 78.4 |
Theng et al (2006) [71] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | <20-y-old female patients | ELISA | 28 | 32.1 |
Theng et al (2006) [71] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | 20–29-y-old women | ELISA | 98 | 49.0 |
Theng et al (2006) [71] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | 30–39-y-old women | ELISA | 40 | 67.5 |
Theng et al (2006) [71] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | >40-y-old women | ELISA | 32 | 78.2 |
Zegans et al (1999) [66] | 1999 | India | Hospital | CS | Conv | Patients with Mooren ulcers | ELISA | 21 | 86.0 |
Clinical Mixed-Age Population (n = 1) | |||||||||
Lee and Lee (2015) [72] | NA | South Korea | Community | CSa | Conv | >11-y-old patients | Multiplex immunoassay | 2317 | 73.8 |
Other Populations (n = 25) | |||||||||
Chu et al (2006) [73] | NA | Thailand | Hospital | CS | Conv | HIV-infected men | ELISA | 66 | 53.0 |
Chu et al (2006) [73] | NA | Thailand | Hospital | CS | Conv | HIV-infected women | ELISA | 70 | 73.0 |
Cowan et al (2003) [56] | 1998–2000 | Sri Lanka | Outpatient clinic | CS | Conv | 15–20-y-old healthy/clinical patients | ELISA | 622b | 74.3 |
Cowan et al (2003) [56] | 1998–2000 | Sri Lanka | Outpatient clinic | CS | Conv | 20–30-y-old healthy/clinical patients | ELISA | 622b | 79.2 |
Cowan et al (2003) [56] | 1998–2000 | Sri Lanka | Outpatient clinic | CS | Conv | 30–35-y-old health/clinical patients | ELISA | 622b | 74.6 |
Cowan et al (2003) [56] | 1998–2000 | Sri Lanka | Outpatient clinic | CS | Conv | 25–40-y-old healthy/clinical patients | ELISA | 622b | 74.5 |
Cowan et al (2003) [56] | 1998–2000 | Sri Lanka | Outpatient clinic | CS | Conv | 40–45-y-old healthy/clinical patients | ELISA | 622b | 77.1 |
Cowan et al (2003) [56] | 1998–2000 | Sri Lanka | Outpatient clinic | CS | Conv | >45-y-old healthy/clinical patients | ELISA | 622b | 82.0 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | Female sex workers | EIA | 70 | 75.7 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | <39-y-old MSM | EIA | 15 | 53.3 |
Hashido et al (1998) [58] | NA | Japan | Community | CS | Conv | >40-y-old MSM | EIA | 19 | 97.4 |
Lin et al (2011) [53] | NA | China | Community | CS | Conv | 18–29-y-old HIV-infected patients | ELISA | 191 | 94.3 |
Lin et al (2011) [53] | NA | China | Community | CS | Conv | 30–39-y-old HIV-infected patients | ELISA | 503 | 92.6 |
Lin et al (2011) [53] | NA | China | Community | CS | Conv | 40–49-y-old HIV-infected patients | ELISA | 290 | 89.7 |
Lin et al (2011) [53] | NA | China | Community | CS | Conv | 50–59-y-old HIV-infected patients | ELISA | 96 | 85.4 |
Lin et al (2011) [53] | NA | China | Community | CS | Conv | 60–94-y-old HIV-infected patients | ELISA | 30 | 93.3 |
Limpakarnjanara et al (1999) [74] | 1994 | Thailand | Community | CS | Conv | >16-y-old female sex workers | WB | 500 | 91.0 |
Neal et al (2011) [75] | NA | China | Community | CS | Conv | Sex workers | WB | 273 | 91.9 |
Qutub and Akhter (2003) [76] | NA | Bangladesh | Community | CSa | Conv | Female sex workers | WB | 463 | 92.7 |
Theng et al (2006) [77] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | 20–29-y-old sex workers | ELISA | 146 | 80.1 |
Theng et al (2006) [77] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | 30–39-y-old sex workers | ELISA | 56 | 67.9 |
Theng et al (2006) [77] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | 40–49-y-old sex workers | ELISA | 60 | 68.3 |
Theng et al (2006) [77] | 2003–2004 | Singapore | Outpatient clinic | CS | Conv | >50-y-old sex workers | ELISA | 38 | 89.5 |
Van Griensven et al (2013) [78] | 2006–2010 | Thailand | Community | CS | Conv | >18-y-old MSM | ELISA | 1740 | 56.5 |
Yap et al (2017) [79] | NA | Malaysia | Hospital | CS | Conv | HIV-infected patients | ELISA | 232 | 70.7 |
Abbreviations: CC, case-control; CFT, complement fixation test; Conv, convenience; CS, cross-sectional; EIA, enzyme immunoassay; ELISA, enzyme-linked immunosorbent assay; HIV, human immunodeficiency virus; HSV-1, herpes simplex virus type 1; HTLV-1, human T-lymphotropic virus 1; MSM, men who have sex with men; NA, not available; PHA, passive hemagglutination assay; RS, random sampling; STD, sexually transmitted disease; STI, sexually transmitted infection; WB, Western blot.
aThe actual study design was cohort, but the extracted seroprevalence measure was for the baseline measurement.
bThe study included overall sample size but no sample sizes for individual strata. Each stratum sample size was assumed to be equal to the overall sample size divided by the number of strata in the study.